An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Completed study 0881A3-312-EU
Agreeable to utilize medically acceptable form of contraception
Able to reconstitute and self-inject or have a designee
Withdrawn from study 0881A3-312-EU
Abnormal hematology or chemistry profiles
Clinically relevant medical conditions including: congestive heart failure, multiple sclerosis or other central demyelinating diseases, blood dyscrasias, cancer or serious infection